London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East and have access to Premium Chat. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
You could well be right about that. New acquisitions usually hold back companies growth over He first 12-24months, but that’s the time to get in!
I think the TESARO acquisition is going to hold back EPS for the next 2 years and limit any share price growth to a certain extent...interesting to see the next quarter results and comments on the dividend proposals for 2019
Bought £11.5k more here this afternoon and sold half of my MYI stake.
I think tech & Biotech will continue this lead in the markets until we get round all the financial matters regarding US v China & Brexit issue.
How much annual return are you aiming for ?
Grayling, sold 40% of holding but did not go too far down the ticker list. GVC - 6 % div plus a fair bit of capital growth if things go ok stateside.
Strange the big director sells just before price fall, only joshing - seems some expect directors to only buy and never sell.
I would personally consider equal portions of:
Legal & General
Bluefield Solar Fundamentals
IT invested in technology stocks
IT invested in smaller companies
The x3 equities will give me 3.00% return on £100k plus the two Investment trusts dividends,
Thus I am invested in drugs, insurance/financials, energy, smaller companies & technology.
When portfolio has made 20k buy into property fund.
"I want to invest 100k into good dividend stocks"...That's a fair amount of wedge pastyc. How many equities are you planning on spreading it among? What's your timescale/object rate of return/maximum tolerable loss?
I meant being open regarding payment of future dividends. Anyway the China thing was years ago, resolved two years ago. Since then a new CEO and hopefully some changes for the better.
RNS looks very positive
From what I gather that was just the Chinese arm of GSK, not the company as a whole. There were also accusations that bribery in the pharmaceuticals industry in china was rife. The government decided they wanted to put a stop to it, and GSK was unlucky enough to be chosen to be made an example of.
Also the SFO have recently closed their investigation into it, and "concluded no further action [was] required"
" At least they (GSK) are honest" ...
I fell off my chair laughing at that one......they werent not so long ago in China , and do have a record oh dodgy goings on abroad ...
At least they (GSK) are honest
AZN has an even thinner cover. Is it justified by better growth prospects than GSK?
I can't see why I would want AZN over GSK, other than sp performance.
GSK recognises the importance of dividends to shareholders and aims to distribute regular dividend payments that will be determined primarily with reference to the free cash flow generated by the business after funding the investment necessary to support the Group's future growth.
The Board intends to maintain the dividend for 2019 at the current level of 80p per share, subject to any material change in the external environment or performance expectations. Over time, as free cash flow strengthens, it intends to build free cash flow cover of the annual dividend to a target range of 1.25-1.50x, before returning the dividend to growth.
They talk a lot about restructuring, and that has a cost
I would take some time and study the accounts and read the last 3 months of RNS to understand the company direction for the next few years....take a look at recent results day videos from the BOD .....and build up an answer to your own question....
The dividend cover here is very, thin with regards free cash flow and they tend to add to the debt when there isnt sufficient to pay the huge dividend bill.
I cant see the dividend rising any time soon, and the company must achieve on its goals to keep the current dividend affordable.... which it is just about managing to do ....but external factors can change things...as we all know
Whilst you might be happy to receive the dividend here, the company itself doesnt get a stronger balance sheet as a result of having to currently afford the expectation ....
The BOD is good and appear to know what they are doing , and where they are heading to....it is more about what external factors which could effect revenues that have to be considered ..such as exchange rates etc ...IMO
Next year is US election year and whoever wins tends to effect Pharma SPs in different ways ....so have an idea of what each side may do to the Pharma Industry in the US ...important to GSK
Whatever you do....dont just park your money in what you think is a good dividend payer.......look at VOD ....see what has happened there !!
The person who will answer your question the best...will be you....
I dont know about any "uproar"with regards recent events ....but...what should be noted is the BOD changed the view that the dividend wouldnt be "progessive" but would be based on results and achieving certain key financial targets ...
I think that made investors uneasy ..as they had come to think the dividend was "safe" no matter how the yearly results were
Dividend has been consistent for the last few years. last time there was talk of reducing the dividend there was uproar and they backed off and continued the 80p/year. It's difficult to say what will happen in the future, especially with brexit looming but based on historical data it's quite a safe stock for dividend.
I want to invest 100k into good dividend stocks and this is one I'm considering.
Appreciate the LTH advice on whether the current SP is a good entry point and opinion to whether you consider the dividend to be safe, currently yielding just over 5%.
Cannot see that transaction here....have you got level2?...if so do you feel it gives you an edge and improves your trading performance
based on historical performance GSK hits it's annual lows in Oct-Dec with occasional smaller dips throughout the rest of the year, slowly recovering and peaking around July. This pattern has repeated since 2012, before which the pattern was reversed, interestingly, but I see no reason for the pattern to reverse again this year.
Brexit is an interesting thing this year though. Difficult to know where it is headed even with only a month to go.
Must admit I was hoping it's sink a bit more as I do like to buy in as low as possible.
5.5 million shares sold in 1 transaction at 16.35, this is definitely going down before it goes up!
I think it is possible to make £15.80. The market is a bit soggy and this was 1581p 2 weeks ago before the divi. A bit of buoyancy in the market could carry us up on a tide of optimism. I am a buyer myself up to 1600p/
This time laste year it was 1307, it was up to 1397 by end of March this dip is a blip.
Just 1 month ago it wax 1436 and still managed to hit 1581 in less than a month, yes people buying before ex-div helped that, but this share price can move around quite a lot over short periods.
it was 1581 just before exdiv, check previous years, share price normally hits a high some time around March/April
No way this is going to £15.80 anytime soon.
Looks like price is recovering after the bad dip yesterday. Here's hoping a gradual climb up to ~1580, which is my sell point, sooner rather than later.